Salute e Benessere

Surgical Suture Market Surges to USD 4.79 Billion by 2030, Propelled by 5.1%…

The surgical suture market is primarily driven by the increasing number of surgeries globally, particularly due to the rising prevalence of chronic diseases, aging populations, and accidents. Advancements in suture technologies, such as bio-absorbable and antimicrobial sutures, further fuel market growth by offering improved patient outcomes and faster recovery times. Additionally, the growing demand for minimally invasive procedures contributes to market expansion. However, the market faces…
PR Newswire
23/01/2025

Ophthalmic Surgical Knives Market is expected to generate a revenue of USD 360…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1067017 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1067017 202 - Pages126 – Tables37 – Figures Scope Of The Report Ophthalmic Surgical Knives Market Overview 1. Market Definition and Scope The Ophthalmic Surgical Knives Market focuses on specialized surgical tools used in ophthalmic surgeries, primarily for cataract, glaucoma, and...
PR Newswire
23/01/2025

Surgical Drills Market to Reach $1.71 Billion by 2031 - Exclusive Report by…

Download FREE PDF Brochure Of Surgical Drills Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6098 Download FREE PDF Brochure Of Surgical Drills Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6098 The growth of this market is driven by the increasing number of surgeries worldwide, technological advancements in surgical drills, the high incidence of accidental injuries, and the growing demand for dental implantation procedures...
PR Newswire
23/01/2025

Medisensonic S.A. Modern medical technologies with growing investment potential

https://www.medisensonic.com/.The company will soon hold a meeting for interested parties to present its strategic plans, adopted business models and talk about its non-invasive medical projects. You can sign up for the meeting athttps://ir.medisensonic.com/.The company, which specializes in designing innovative diagnostic devices, is working on a needle-free glucose meter called Glucowave that will mean a change in the standard of living for more than 800 million diabetics....
Nasdaq GlobeNewswire
23/01/2025

Next-Generation Sequencing Services Market Poised for Remarkable Growth…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1018094 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1018094 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Next-Generation Sequencing (NGS) Services Market Overview Market Growth and Size The Next-Generation Sequencing (NGS) Services Market is on a robust growth trajectory, expected to expand from approximatelyUSD 7 billionin...
PR Newswire
23/01/2025

Gene Transfer Technologies Market to Hit US$5.93 Billion by 2029 with 9.7% CAGR…

Browse in-depth TOC on "Gene Transfer Technologies Market" Browse in-depth TOC on "Gene Transfer Technologies Market" 771 - Tables 56 - Figures 524 - Pages The product segment is segmented into instruments, consumables, reagents, kits & assays, and other products. The reagents, kits & assays gene transfer technologies segment dominated product segments owing to various factors such as increasing adoption of gene therapies and cell therapies across pharmaceutical…
PR Newswire
23/01/2025

Vaccine Storage Equipment Market to Hit US$1.21 Billion by 2029 with 7.2% CAGR |…

Browse in-depth TOC on "Vaccine Storage Equipment Market" Browse in-depth TOC on "Vaccine Storage Equipment Market" 300 - Tables50 - Figures300 - Pages Based on product,the vaccine storage equipment market is divided into refrigerators, freezers, vaccine carriers/cold boxes, monitoring devices, and others. Among these, in 2023, the refrigerator segment accounted for the highest market share in the vaccine storage equipment market. This is owing to increasing investments...
PR Newswire
23/01/2025

Mental Health Apps Market is expected to generate a revenue of USD 17.5 Billion…

The global demand for mental health solutions is at an all-time high, driven by increased awareness, workplace initiatives, and the integration of technology in healthcare. Mental health apps have emerged as a pivotal tool in bridging the gap between patients and accessible care. Verified Market Research®'s upcoming report offers in-depth analysis of key market drivers, technological advancements, regulatory landscapes, and competitive dynamics shaping this burgeoning industry. The global...
PR Newswire
23/01/2025

Tiziana Life Sciences not to engage in capital raising activities for the…

Following on from its news yesterday of the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated with nasal foralumab, the Company has decided not to engage in a capital raising activities for the immediate future.Tiziana's management team remains committed to delivering value to its shareholders and advancing its innovative drug candidates through clinical trials and regulatory processes. About Tiziana Life Sciences ...
Nasdaq GlobeNewswire
23/01/2025

Coway Issues Official Statement Responding to Align Partners' Shareholder's…

The shareholder's proposal requested a dividend rate that represents approximately 90% of the company's consolidated net income. The shareholder's proposal requested a dividend rate that represents approximately 90% of the company's consolidated net income. This figure significantly exceeds the target shareholder return rate of 40% as outlined in Coway's shareholder return policy announced onJanuary 6th, which takes into consideration the company's financial stability and long-term...
PR Newswire
23/01/2025

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA BiogenInc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) and the European Medicines Agency (EMA) has validated the application for a higher dose regimen of nusinersen for spinal muscular atrophy (SMA). The higher dose...
Nasdaq GlobeNewswire
23/01/2025

Veeva and Zifo Partner to Accelerate Quality Control Modernization

"We are excited to partner with Veeva to offer powerful solutions to the life sciences industry," said Kannan Jagamoorthy, general manager and head of Zifo North America. "Our collaboration will help customers expedite their adoption of Veeva LIMS to streamline operations." "We are excited to partner with Veeva to offer powerful solutions to the life sciences industry," said Kannan Jagamoorthy, general manager and head of Zifo North America. "Our collaboration…
PR Newswire
23/01/2025

Synthetic Leather Market worth $93.25 billion by 2029 - Exclusive Report by…

302 – Tables 50 – Figures244 – Pages 302 – Tables 50 – Figures 244 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6616309 PU based, by type segment is expected to be second fastest growing type for synthetic leather market during the forecasted period. PU synthetic leather is expected to be the second fastest-growing segment of the synthetic leather market during the forecast period due to its superior qualities, such...
PR Newswire
23/01/2025

Flagship Pioneering, Cambridge University Health Partners, and Milner…

LONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies. LONDON , Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science...
PR Newswire
23/01/2025

Myant Brings the Future of Disease Prevention to Arab Health 2025

Showcasing the Future of Disease Prevention Showcasing the Future of Disease Prevention Myant will present Myant Care, a comprehensive platform which combines health data to predict and prevent disease, keeping populations healthy by providing early warnings and interventions. Myant Care uses clinical-grade interfaces for real medical decisions, leveraging deep machine learning to transform continuous health data and scientific literature into actionable care plans. Central to the...
PR Newswire
23/01/2025

First Breakthrough Study Highlights Superiority of MatriDerm® in Wound Healing

The study, led by Prof. JP. Hong, Dr. J. Maitz, and Dr. M. Mörgelin, demonstrates that MatriDerm® facilitates superior cell adhesion, proliferation, and differentiation, leading to more effective tissue regeneration and wound healing. Additionally, MatriDerm®'s natural composition, made of native collagen and elastin, results in lower immunogenicity, minimizing adverse inflammatory reactions compared to synthetic matrices. The study, led by Prof. JP. Hong, Dr. J. Maitz, and Dr. M. Mörgelin,...
PR Newswire
23/01/2025

Report for quarter 4 and full-year 2024: Essity

Quarter 4, 2024 Quarter 4, 2024 Full-year 2024 CEO'S COMMENTS Essity is in better shape than ever and our focus on accelerated profitable growth is yielding results. For full-year 2024, sales amounted toSEK 146bnand profit reached its highest level ever atSEK 20.3bn. Strong growth and crucial innovation Sales increased in all of Essity's business areas in the fourth quarter. High organic growth was noted in our most profitable categories: Incontinence Products,...
PR Newswire
23/01/2025

FUTURE OF HEALTH: CARDONE VENTURES PARTNERS WITH REVIV TO LAUNCH THE WORLD'S…

Revolutionizing Health with Unmatched Genetic Insights Revolutionizing Health with Unmatched Genetic Insights The 10X Precision Genetic Test combines cutting-edge technology with artificial intelligence to analyze up to 20 million genetic variations, delivering unparalleled insights into an individual's biological data with 99.97% accuracy. Developed inAustriaby renowned biotechnologist Dr. Daniel Wallerstorfer, PhD, the system represents the pinnacle of precision health science...
PR Newswire
23/01/2025

Chronic Heart Failure Market to Observe Stunning Growth at a CAGR of 10% by 2034…

Key Takeaways from the Chronic Heart Failure Market Report Key Takeaways from the Chronic Heart Failure Market Report Discover which therapies are expected to grab the major chronic heart failure market share @ Chronic Heart Failure Market Report Chronic Heart Failure Overview Chronic heart failure is a long-term condition in which the heart's ability to pump blood efficiently is reduced, leading to inadequate circulation of oxygen and nutrients to meet the body's needs...
PR Newswire
22/01/2025

Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma…

Key Takeaways from the Tuberculosis Pipeline Report Key Takeaways from the Tuberculosis Pipeline Report Request a sample and discover the recent advances in tuberculosis treatment drugs @Tuberculosis Pipeline Report The tuberculosis pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage tuberculosis drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment...
PR Newswire
22/01/2025

Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple…

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include modulation of: FoxP3 T regulatory cells (Tregs)CD4+ and CD8+ central memory T cellsCD14+ and CD14- monocytesNaïve B cells These pathways are known to be associated with antigen presentation, interferon responses, and other regulatory immune mechanisms.In this study, single-cell RNA...
Nasdaq GlobeNewswire
22/01/2025

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in…

Daix (France), New York City (New York, United States), January 22, 2025– Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”) and other diseases with significant unmet medical needs, today announced that the results from its Proof-of-Concept trial evaluating lanifibranor in combination...
Nasdaq GlobeNewswire
22/01/2025

President and CEO Magnus Groth will leave Essity during 2025

"It has been very stimulating to work as President and CEO since 2015, first for SCA and then for Essity, and I especially appreciate the collaboration with colleagues all over the world," says Magnus Groth. "Essity is today a world-leading hygiene and health company with strong brands and market positions, great employees and recognized sustainability work, reflected in profitable growth. After 14 years with the company and ten years as CEO, I consider this a suitable time to…
PR Newswire
22/01/2025

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to…

Dr. Anna Wu, Founder of ImaginAb, commented, "We are very pleased that Telix recognizes the potential of our novel biological technology platform including enabling Telix to explore new disease areas with state-of-the-art radiotherapeutic technology. These radiopharmaceutical agents represent the culmination of significant effort and resources by our scientific team. I extend my congratulations to everyone at ImaginAb for reaching this significant milestone. This transaction further…
PR Newswire
22/01/2025
Altri  Comunicati